John J. Aponte

PATH

2201 Westlake Avenue, Suite 200

Seattle, WA 98121

United States

SCHOLARLY PAPERS

2

DOWNLOADS

93

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Immunogenicity and Safety of Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine in Girls 9–14 Years of Age in Low- and Middle-Income Countries: Final Data of Randomized Controlled Trial

Number of pages: 34 Posted: 08 Nov 2024
Agogo Malaria Research Centre, PATH, Kwame Nkrumah University of Science and Technology, Ghana, PATH, PATH, Kwame Nkrumah University of Science and Technology, Ghana, International Vaccine Institute, International Centre for Diarrheal Disease Research (ICDDR’B), Government of the United States of America - HPV Serology Laboratory, PATH, Government of the United States of America - HPV Serology Laboratory, International Centre for Diarrheal Disease Research (ICDDR’B) - Infectious Disease Division, PATH, PATH and International Centre for Diarrheal Disease Research (ICDDR’B) - Infectious Diseases Division
Downloads 73 (658,483)

Abstract:

Loading...

Human papillomavirus (HPV), HPV vaccine, immunization, immunobridging, one-dose immunogenicity

2.

A Multi-Center, Observer-Blind, Randomized, Phase 3 Study to Evaluate Safety, Non-Inferiority of Multi-Dose and Single-Dose Vial Formulations of EuTCV (Vi-CRM197 Typhoid Conjugate Vaccine) and Lot-to-Lot Consistency of the Immune Response to Multi-Dose Vial Formulation EuTCV in Healthy Participants in Kenya and Senegal

Number of pages: 19 Posted: 24 Jan 2025
Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Kenya Medical Research Institute (KEMRI) - Kenya Medical Research Institute (KEMRI)/Walter Reed Project, Institute for Disease Modeling, PATH, Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Kenya Medical Research Institute (KEMRI), Kenya Medical Research Institute (KEMRI), Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), Institute for Health Research - Epidemiological Surveillance and Training (IRESSEF), PATH, PATH, PATH, PATH, PATH, University of Paris-Saclay - Institut Pasteur, Institut Pasteur de Dakar, Institut Pasteur de Dakar, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center, EuBiologics R&D Center and World Health Organization (WHO) - Global Malaria Programme
Downloads 20 (1,066,476)

Abstract:

Loading...

Africa, Kenya, Senegal, EuTCV, Typhoid, adults, children, infants, conjugate vaccine, safety, immunogenicity, intramuscular.